Q2 2026 Earnings Call February 4, 2026 4:30 PM ESTCompany ParticipantsSteven Fife - President, CEO & DirectorCarl Aure ...

McKesson Corporation raised its fiscal 2026 profit forecast on Wednesday, betting on strong growth in its oncology and specialty drug distribution businesses.

The International Society of Pharmaceutical Engineering (ISPE) has announced the 2026 FOYA submission finalists. The announcement was made at the 2026 ISPE Facilities of the Future Conference in San ...

• What disappointing pharma guidance from Novo Nordisk, Pfizer and Merck reveals about sentiment beyond tech ...

Eli Lilly rated SELL: rich valuation priced for perfection, rising GLP-1 competition, pricing pressure, and patent-cliff risk. Click here to read more on LLY stock.

Shares of pharmaceutical giant Pfizer (NYSE: PFE) have been crashing for multiple years. The last time it posted a positive ...

It had broad bipartisan support but passage still required years of heartbreaking lobbying by extraordinarily dedicated ...

Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...

Merck & Co forecasts lower 2026 sales and profits due to post-patent challenges for key drugs like Januvia, despite strong performance from Keytruda. The company's proactive measures include ...

Africa's health future hinges on its ability to finance and commercialize its own medical innovations, rather than rely on ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...